FindTrial
Sign In

Punch skin biopsy

PROCEDURE4 trials

Sponsors

Washington University School of Medicine, University Ghent, Cairo University, University Hospitals Cleveland Medical Center

Conditions

Acute Myeloid LeukemiaAndrogenetic AlopeciaCorticobasal DegenerationDementia With Lewy BodiesDiaper RashIncontinence-associated DermatitisIrritant Contact DermatitisMultiple System Atrophy

Phase 2

Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
Active, not recruitingNCT02756962
Washington University School of MedicineAcute Myeloid Leukemia
Start: 2016-07-06End: 2029-07-31Updated: 2025-10-28

Unknown Phase

Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
CompletedNCT03685929
University GhentDiaper Rash, Incontinence-associated Dermatitis, Irritant Contact Dermatitis +1
Start: 2018-10-01End: 2019-12-31Updated: 2021-11-29
Androgenetic Alopecia and the JAK-STAT Pathway
CompletedNCT03694067
Cairo UniversityAndrogenetic Alopecia
Start: 2018-10-15End: 2019-12-01Updated: 2020-01-28
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
CompletedNCT04518059
University Hospitals Cleveland Medical CenterCorticobasal Degeneration, Dementia With Lewy Bodies, Multiple System Atrophy +3
Start: 2019-03-12End: 2025-05-31Updated: 2025-07-01

Related Papers

Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia.
2026-08-25
Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial
Blood2024-11-051 citations
Comparison of Deep Whole Exome Versus Targeted Gene Sequencing for Assessment of Persistent Molecular Disease in Acute Myeloid Leukemia Samples
Blood2020-11-05
Improving Risk Assessment of AML with a Precision Genomic Strategy to Assess Mutation Clearance
Blood2018-11-29